Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer
- John P. Crown
- , Véronique Diéras
- , Elzbieta Staroslawska
- , Denise A. Yardley
- , Thomas Bachelot
- , Neville Davidson
- , Hans Wildiers
- , Peter A. Fasching
- , Olivier Capitain
- , Manuel Ramos
- , Richard Greil
- , Francesco Cognetti
- , George Fountzilas
- , Maria Blasinska-Morawiec
- , Cornelia Liedtke
- , Rolf Kreienberg
- , Wilson H. Miller
- , Vanessa Tassell
- , Xin Huang
- , Jolanda Paolini
*Korrespondierende/r Autor/-in für diese Arbeit
- Irish Cooperative Oncology Research Group
- Institut Curie
- Centrum Onkologii Ziemi Lubelskiej
- Sarah Cannon Research Institute
- Centre Leon Berard
- Mid Essex Hospital Services
- Katholieke Universiteit Leuven
- Friedrich-Alexander-Universität Erlangen-Nürnberg
- Centre Paul Papin
- Centro Oncologico de Galicia
- Paracelsus Medizinische Privatuniversität
- Istituto Regina Elena
- Aristotle University of Thessaloniki School of Medicine
- Wojewodzki Szpital Specjalistyczny
- Universität Ulm
- Segal Cancer Centre of Jewish General Hospital
- McGill University
- Pfizer Inc.
- Regional Centre for the Fight Against Cancer Val d'Aurelle Paul-Lamarque
- Institut Régional du Cancer de Montpellier (ICM)
137
Link wird in einem neuen Tab geöffnet
Zitate
(Scopus)